The endoplasmic reticulum-nuclei-1 (ERN1) sensing and signaling enzyme mediates a set of complex intracellular signaling events known as the unfolded protein response. We have studied the effect of hypoxia and ischemic conditions (glucose or glutamine deprivation) on the expression of several casein kinase-1 and -2 genes in glioma U87 cells and its subline with suppressed function of ERN1. It was shown that blockade of ERN1, the key endoplasmic reticulum stress sensor, leads to an increase in the expression levels of casein kinase-1G2, -1E, -2B and NUCKS1 mRNA, but suppresses casein kinase-1A1, -1D and -2A1. Moreover, the expression levels of casein kinase-1A1, -1D and 1G3 as well as casein kinase-2A1 and -2A2 mRNAs are significantly increased under glutamine dep- rivation conditions both in control and ERN1- deficient glioma cells. At the same time, casein kinase-1E, -2B and NUCKS1 mRNA expression levels are also increased under this condition, but only in cells with suppressed function of ERN1. The expression level of NUCKS1 mRNA, however, is decreased both in control glioma cells and in genetically modified cells, but casein kinase-1G2—only in control U87 cells. Cell exposure to glucose deprivation conditions enhances the expression levels of casein kinase- 1D, 1G3, -1E and -2A1 in both types of glioma cells used, but casein kinase-2B expression levels increase only in cells with suppressed function of ERN1. Hypoxia induces or suppresses the expression of most of the studied genes mainly in ERN1-knockdown cells only. Results of this study show that hypoxia as well as glutamine and glucose deprivation conditions change the expression level most of casein kinase genes and that these effects are dependent on ERN1 signaling enzyme function.
KeywordsmRNA ExpressionCasein Kinase 1A1D1G21G31E2A12A22B and NUCKS1Glioma CellsEndoplasmic Reticulum-Nuclei-1 (ERN1
Aragón, T., Van Anken, E., Pincus, D., Serafimova, I.M., Korennykh, A.V., Rubio, C.A. and Walter P. (2009) Messenger RNA targeting to endoplasmic reticulum stress signalling sites. Nature, 457, 736-740. doi:10.1038/nature07641
Bi, M., Naczki, C., Koritzinsky, M., Fels, D., Blais, J., Hu, N., Harding, H., Novoa, I., Varia, M., Raleigh, J., Scheuner, D., Kaufman, R.J., Bell, J., Ron, D., Wouters, B.G. and Koumenis, C. (2005) ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO Journal, 24, 3470-3481. doi:10.1038/sj.emboj.7600777
Blais, J.D., Filipenko, V., Bi, M., Ron, D., Koumenis, C., Wouters, B.G. and Bell, J.C. (2004) Transcription factor 4 is translationally regulated by hypoxic stress. Molecular Cell Biology, 24, 7469-7482. doi:10.1128/MCB.24.17.7469-7482.2004
Fels, D.R. and Koumenis, C. (2006) The PERK/eIF2a/ ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biology & Therapy, 5, 723-728. doi:10.4161/cbt.5.7.2967
Luo, D., He, Y., Zhang, H., Yu, L., Chen, H., Xu, Z., Tang, S., Urano, F. and Min, W. (2008) AIP1 is critical in transducing IRE1-mediated endoplasmic reticulum stress response. The Journal of Biological Chemistry, 283, 11905-11912. doi:10.1074/jbc.M710557200
Korennykh, A.V., Egea, P.F., Korostelev, A.A., Finer-Moore, J., Zhang, C., Shokat, K.M., Stroud, R.M. and Walter, P. (2009) The unfolded protein response signals through high-order assembly of Ire1. Nature, 457, 687-693. doi:10.1038/nature07661
Romero-Ramirez, L., Cao, H., Nelson, D., Hammond, E., Lee, A.H., Yoshida, H., Mori, K., Glimcher, L.H., Denko, N.C., Giaccia, A.J., Le, Q.-T. and Koong, A.C. (2004) XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Research, 64, 5943-5947. doi:10.1158/0008-5472.CAN-04-1606
Lin, J.H., Li, H., Yasumura, D. Cohen, H.R., Zhang, C., Panning, B., Shokat, K.M., Lavail, M.M. and Walter, P. (2007) IRE1 signaling affects cell fate during the unfolded protein response. Science, 318, 944-949. doi:10.1126/science.1146361
Hollien, J., Lin, J.H., Li, H., Stevens, N., Walter, P. and Weissman, J.S. (2009) Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. The Journal of Cell Biology, 186, 323-331. doi:10.1083/jcb.200903014
Acosta-Alvear, D., Zhou, Y., Blais, A., Tsikitis, M., Lents, N.H., Arias, C., Lennon, C.J., Kluger, Y. and Dynlacht D.D. (2007) XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Molecular Cell, 27, 53-66. doi:10.1016/j.molcel.2007.06.011
IRE-1α)
Hypoxia
Glucose and Glutamine Deprivation
Han, D., Upton, J.-P., Hagen, A., Callahan, J., Oakes, S.A. and Papa, F.R. (2008) A kinase inhibitor activates the IRE1alpha RNase to confer cytoprotection against ER stress. Biochemical and Biophysical Research Communications, 365, 777-783. doi:10.1016/j.bbrc.2007.11.040
Greenman, C., Stephans, P., Smith, R. Dalgliesh, G.L., Hunter, C., Bignell, G., Davies, H., et al. (2007) Patterns of somatic mutation in human genomes. Nature, 446, 153-158. doi:10.1038/nature05610
Auf, G., Jabouille, A., Guérit, S., Pineau, R., Delugin, M., Bouchecareilh, M., Favereaux, A., Maitre, M., Gaiser, T., Von Deimling, A., Czabanka, M., Vajkoczy, P., Chevet, E., Bikfalvi, A. and Moenner, M. (2010) A shift from an angiogenic to invasive phenotype induced in malignant glioma by inhibition of the unfolded protein response sensor IRE1. Proceedings of the National Academy of Sciences of the United States of America, 107, 15553- 15558. doi:10.1073/pnas.0914072107
Drogat, B., Auguste, P., Nguyen, D.T., Bouchecareilh, M., Pineau, R., Nalbantoglu, J., Kaufman, R.J., Chevet, E., Bikfalvi, A. and Moenner, M. (2007) IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor—A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Research, 67, 6700-6707. doi:10.1158/0008-5472.CAN-06-3235
Moenner, M., Pluquet, O., Bouchecareilh, M. and Chevet, E. (2007) Integrated endoplasmic reticulum stress responses in cancer. Cancer Research, 67, 10631-10634. doi:10.1158/0008-5472.CAN-07-1705
Denko, N.C. (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nature Reviews Cancer, 8, 705-713. doi:10.1038/nrc2468
Saito, A., Ochiai, K., Kondo, S., Tsumagari, K., Murakami, T., Cavener, D.R. and Imaizumi, K. (2011) Endoplasmic reticulum stress response mediated by the PERK- eIF2-ATF4 pathway is involved in osteoblast differentiation induced by BMP2. The Journal of Biological Chemistry, 286, 4809-4818. doi:10.1074/jbc.M110.152900
Hetz, C. and Glimcher, L.H. (2009) Fine-tuning of the unfolded protein response: Assembling the IRE1alpha interactome. Molecular Cell, 35, 551-561. doi:10.1016/j.molcel.2009.08.021
Hunt, T. and Sassone-Corsi, P. (2007) Riding tandem: Circadian clocks and the cell cycle. Cell, 129, 461-464. doi:10.1016/j.cell.2007.04.015
Hua, H., Wang, Y., Wan, C., Liu, Y., Zhu, B., Yang, C., Wang, X., Wang, Z., Cornelissen-Guillaume, G. and Hal- berg, F. (2006) Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Science, 97, 589-596. doi:10.1111/j.1349-7006.2006.00225.x
Cao, Q., Gery, S., Dashti, A., Yin, D., Zhou, Y., Gu, J. and Koeffler, H.P. (2009) A role for the clock gene per1 in prostate cancer. Cancer Research, 69, 7619-7625. doi:10.1158/0008-5472.CAN-08-4199
Chen, S.T., Choo, K.B., Hou, M.F., Yeh, K.T., Kuo, S.J. and Chang, J.G. (2005) Rhythmic PER abundance definesa critical nodal point for negative feedback within the circadian clock mechanism. Carcinogenesis, 26, 1241- 1246. doi:10.1093/carcin/bgi075
Taniguchi, H., Fernandez, A.F. and Setien, F. (2009) Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Research, 69, 8447-8454. doi:10.1158/0008-5472.CAN-09-0551
Climent, J., Perez-Losada, J., Quigley, D.A., Kim, I.J., Delrosario, R., Jen, K.Y., Bosch, A., Lluch, A., Mao, J.H. and Balmain, A. (2010) Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer. Journal of Clinical Oncology, 28, 3770-3778. doi:10.1200/JCO.2009.27.0215
Huang, W., Ramsey, K.M. and Marcheva, B. (2011) Circadian rhythms, sleep, and metabolism. The Journal of Clinical Investigation, 121, 2133-2141. doi:10.1172/JCI46043
Borgs, L., Beukelaers, P., Vandenbosch, R., Belachew, S., Nguyen, L. and Malgrange, B. (2009) Cell “circadian” cycle: New role for mammalian core clock genes. Cell Cycle, 8, 832-837. doi:10.4161/cc.8.6.7869
Mizoguchi, T., Putterill, J. and Ohkoshi, Y. (2006) Kinase and phosphatase: The cog and spring of the circadian clock. International Review of Cytology, 250, 47-72. doi:10.1016/S0074-7696(06)50002-6
Walton, K.M., Fisher, K., Rubitski, D., Marconi, M., Meng, Q.J., Sládek, M., Adams, J., Bass, M., Chandrase- karan, R., Butler, T., Griffor, M., Rajamohan, F., Serpa, M., Chen, Y., Claffey, M., Hastings, M., Loudon, A., Maywood, E., Ohren, J., Doran, A. and Wager, T.T. (2009) Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period. Journal of Pharmacology and Experimental Therapeutics, 330, 430-439. doi:10.1124/jpet.109.151415
Meng, Q.J., Maywood, E.S., Bechtold, D.A., Lu, W.Q., Li, J., Gibbs, J.E., Dupré, S.M., Chesham, J.E., Rajamohan, F., Knafels, J., Sneed, B., Zawadzke, L.E., Ohren, J.F., Walton, K.M., Wager, T.T., Hastings, M.H. and Loudon, A.S. (2010) Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proceedings of the National Academy of Sciences of the United States of America, 107, 15240-15245. doi:10.1073/pnas.1005101107
Sprouse, J., Reynolds, L., Swanson, T.A. and Engwall, M. (2009) Inhibition of casein kinase I epsilon/delta produces phase shifts in the circadian rhythms of Cynomolgus monkeys. Psychopharmacology (Berl), 204, 735-742. doi:10.1007/s00213-009-1503-x
Takano, A., Hoe, H.S., Isojima, Y. and Nagai, K. (2004) Analysis of the expression, localization and activity of rat casein kinase 1epsilon-3. Neuro Report, 15, 1461-1464. doi:10.1097/01.wnr.0000133297.77278.81
Rumpf, C., Cipak, L., Dudas, A., Benko, Z., Pozgajova, M., Riedel, C.G., Ammerer, G., Mechtler, K. and Gregan, J. (2010) Casein kinase 1 is required for efficient removal of Rec8 during meiosis I. Cell Cycle, 9, 2657-2662. doi:10.4161/cc.9.13.12146
Foldynová-Trantírková, S., Sekyrová, P., Tmejová, K., Brumovská, E., Bernatík, O., Blankenfeldt, W., Krejcí, P., Kozubík, A., Dolezal, T., Trantírek, L. and Bryja, V. (2010) Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Breast Cancer Research, 12, R30. doi:10.1186/bcr2581
Witte, F., Bernatik, O., Kirchner, K., Masek, J., Mahl, A., Krejci, P., Mundlos, S., Schambony, A., Bryja, V. and Stricker, S. (2010) Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2. The FASEB Journal, 24, 2417-2426. doi:10.1096/fj.09-150615
Venerando, A., Marin, O., Cozza, G., Bustos, V.H., Sarno, S. and Pinna, LA. (2010) Isoform specific phosphorylation of p53 by protein kinase CK1. Cellular and Molecular Life Sciences, 67, 1105-1118. doi:10.1007/s00018-009-0236-7
Guo, X., Waddell, D.S., Wang, W., Wang, Z., Liberati, N.T., Yong, S., Liu, X. and Wang, X.F. (2008) Ligand- dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling. Oncogene, 27, 7235-7247. doi:10.1038/onc.2008.337
Hessenauer, A., Schneider, C.C., Gotz, C. and Montenarh, M. (2011) CK2 inhibition induces apoptosis via the ER stress response. Cellular Signalling, 23, 145-151. doi:10.1016/j.cellsig.2010.08.014
Minchenko, D.M., Hubenya, O.V., Terletsky, B.M., Moenner, M. and Minchenko, O.H. (2011) Effect of hypoxia, glutamine and glucose deprivation on the expression of cyclin and cyclin-dependent kinase genes in glioma cell line U87 and its subline with suppressed activity of signaling enzyme endoplasmic reticulum-nu- clei-1. Ukrainian Biochemical Journal, 83, 5-16.